InsiderTrades.com logo
New CBOE “special perk” helps traders target income every weekend
From DTI Trader   |   Ad
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

SRX Insider Trading

Insider Ownership Percentage: 5.44%
Insider Buying (Last 12 Months): A$10,973.75
Insider Selling (Last 12 Months): A$0.00

Sierra Rutile Insider Trading History Chart

This chart shows the insider buying and selling history at Sierra Rutile by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sierra Rutile Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 09/26/2018 01:00 AM ET

This chart shows the closing price history over time for SRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Sierra Rutile Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2023Graham DavidsonInsiderBuy29,900A$0.20A$5,980.00
5/2/2023Joanne PalmerInsiderBuy21,250A$0.24A$4,993.75
8/9/2022Martin AlciaturiInsiderBuy100,000A$0.26A$26,000.00
See Full Table
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Sierra Rutile (ASX:SRX)

44.74% of Sierra Rutile stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sierra Rutile logo
Sierra Rutile Holdings Limited engages in the multi-deposit mineral sands mining operations in the Middle East, Asia, Europe, and North and South America. It primarily produces natural rutile. The company holds interest in the Sembehun project located in Moyamba district in Sierra Leone. Its products are used in paints, laminates, plastic pipes and packaging, inks, clothing, sunscreen, toothpaste, and the cosmetic industry, as well as aeronautics, medical implants, defense, and sporting goods applications. The company was incorporated in 2016 and is based in Perth, Australia.
Read More on Sierra Rutile

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

0.89%

Beta

5.19

Who are the company insiders with the largest holdings of Sierra Rutile?

Sierra Rutile's top insider investors include:
  1. Graham Davidson (Insider)
  2. Joanne Palmer (Insider)
  3. Martin Alciaturi (Insider)
Learn More about top insider investors at Sierra Rutile.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.